The Neurologist · 2007 · 29 citations · 17 references
MedicineNeurologyOncologyDementiaNeuro-oncologyNeuropathologyBrain TumorsCentral Nervous System LymphomaCentral Nervous System TumorsDementia DiagnosisDementia PrognosisLymphoid TumorsCentral Nervous System Lymphoma PathologyCerebrospinal Fluid 14-3-3 ProteinImmunohistochemical DetectionImmunohistochemical MarkersLymphoid Neoplasm DiagnosisLymphoma HistopathologyLymphoma PathogenesisRapidly Progressive Dementia Assessment
BACKGROUND: As the population ages, the incidence of dementing illness is increasing. Accurate and timely diagnosis provides the best hope for instituting appropriate treatment and educating the patient and family members as to prognosis based upon likely etiology in a given patient. REVIEW SUMMARY: We present a case of an elderly patient referred to our tertiary-care center for further evaluation of a rapidly progressive dementia, whose definitive diagnosis was delayed by nonspecific MRI findings, presence of 14-3-3 protein in the CSF, and nonspecific cutaneous lesions. At brain biopsy, he was thought to have a diffusely infiltrating lymphoma, with distinctive immunohistochemical features. CONCLUSION: This case is notable in that it presents a patient with progressive dementia whose diagnosis of primary central nervous system lymphoma (PCNSL) was delayed because of the lymphoma's atypical diffusely infiltrating nature. Awareness of this unique presentation may hasten the time between clinical presentation, diagnosis, and subsequent treatment.
17
Increasing incidence of primary brain lymphoma in the US
Nancy Eby, Seymour Grufferman, Christina M. Flannelly et al. · Cancer · 1988 · 388 citations · Full text
A multicenter study of treatment of primary CNS lymphoma
Andrés J.M. Ferreri, Michele Reni, Felice Pasini et al. · Neurology · 2002 · 365 citations
Medicine, Oncology, Pharmacotherapy +11
Andrés J.M. Ferreri, Lauren E. Abrey, Jean‐Yves Blay et al. · Journal of Clinical Oncology · 2003 · 181 citations